Showing results (1531-1540 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathwaysClément Morgat, Elif Hindié, Anil K Mishra, et al.Cancer Biotherapy & Radiopharmaceuticals|March 8, 2013
Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imagingMostafa Erfani, Mohammad Shafiei, Mohammad Mazidi, et al.Cancer Biotherapy & Radiopharmaceuticals|March 8, 2013
Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysisLing Li, Shiting Huang, Xiaodong Zhu, et al.Cancer Biotherapy & Radiopharmaceuticals|March 13, 2013
Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transitionFeng Gao, Zhijun Sun, Xin Sun, et al.Cancer Biotherapy & Radiopharmaceuticals|February 19, 2013
The radioprotective effects of Origanum vulgare extract against genotoxicity induced by (131)I in human blood lymphocyteSanam Arami, Amirhossein Ahmadi, S Abolghasem HaeriCancer Biotherapy & Radiopharmaceuticals|December 24, 2011
Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediateCody P Coyne, Toni Jones, Ryan BearCancer Biotherapy & Radiopharmaceuticals|December 21, 2012
Overexpression of Smac promotes Cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cellsSida Qin, Chengcheng Yang, Xifang Wang, et al.Cancer Biotherapy & Radiopharmaceuticals|August 13, 2013
Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acidsKusum Vats, Tapas Das, Haladhar D Sarma, et al.Cancer Biotherapy & Radiopharmaceuticals|August 23, 2013
Radiofrequency ablation before intratumoral injection of (131)I-chTNT improves the tumor-to-normal tissue ratio in solid VX2 tumorShu-Guang Zheng, Hui-Xiong Xu, Ming-De Lu, et al.Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
LnPO4 nanoparticles doped with Ac-225 and sequestered daughters for targeted alpha therapyMark F McLaughlin, David Robertson, Paul H Pevsner, et al.Pageof 224